Seasonal epidemiological variation of human African trypanosomiasis in Babati District, Tanzania
Calvin Sindato+5 more
openalex +2 more sources
Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of Analogues. [PDF]
Cleghorn LAT+21 more
europepmc +1 more source
Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis [PDF]
Pere P. Simarro+4 more
openalex +1 more source
Structure-Activity Relationships, Tolerability and Efficacy of Microtubule-Active 1,2,4-Triazolo[1,5-a]pyrimidines as Potential Candidates to Treat Human African Trypanosomiasis. [PDF]
Monti L+11 more
europepmc +1 more source
Human African trypanosomiasis in a Belgian traveller returning from the Masai Mara area, Kenya, February 2012 [PDF]
Jan Clerinx+5 more
openalex +1 more source
A modelling assessment of short- and medium-term risks of programme interruptions for gambiense human African trypanosomiasis in the DRC. [PDF]
Huang CI+7 more
europepmc +1 more source
Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan [PDF]
Francesco Checchi+5 more
openalex +1 more source
SHERLOCK4HAT: A CRISPR-based tool kit for diagnosis of Human African Trypanosomiasis. [PDF]
Sima N+5 more
europepmc +1 more source
Risk factors and prevalence of human African trypanosomiasis in individuals living in remote areas of the republic of Congo. [PDF]
Elenga VA+7 more
europepmc +1 more source
Eliminating Human African Trypanosomiasis: Where Do We Stand and What Comes Next?
Pere P. Simarro, J Jannin, P Cattand
openalex +2 more sources